Andra AP fonden buys 9,900 shares of Align Technology, Inc. (NASDAQ:ALGN)

Andra AP fonden raised its position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 137.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,100 shares of the medical equipment provider’s stock after acquiring an additional 9,900 shares during the quarter. Andra AP fonden’s holdings in Align Technology were worth $4,128,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have recently modified their positions in ALGN. Gryphon Financial Partners LLC raised its position in shares of Align Technology by 31.0% during the fourth quarter. Gryphon Financial Partners LLC now owns 1,396 shares of the medical equipment provider’s stock worth $383,000 after acquiring an additional 330 shares in the last quarter. Principal Securities Inc. bought a new stake in Align Technology in the fourth quarter valued at about $199,000. QRG Capital Management Inc. boosted its holdings in Align Technology by 5.0% in the fourth quarter. QRG Capital Management Inc. now owns 3,248 shares of the medical equipment provider’s stock valued at $890,000 after purchasing an additional 156 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Align Technology by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 213,667 shares of the medical equipment provider’s stock worth $58,548,000 after purchasing an additional 7,266 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in Align Technology by 3.5% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 7,271 shares of the medical equipment provider’s stock valued at $1,992,000 after purchasing an additional 248 shares in the last quarter. Institutional investors own 88.43% of the company’s shares.

Insider Trading at Align Technology

In other news, Director C Raymond Larkin, Jr. purchased 6,500 shares of Align Technology stock in a transaction dated Thursday, August 15th. The shares were bought at an average cost of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now directly owns 28,247 shares of the company’s stock, valued at $6,647,366.51. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available via this hyperlink. 0.62% of shares are held by insiders.

Aligning tech deals down 0.9%

NASDAQ:ALGN opened at $225.15 on Thursday. Align Technology, Inc. has a 1 year low of $176.34 and a 1 year high of $335.73. The stock has a market cap of $16.95 billion, a price-to-earnings ratio of 37.09, a PEG ratio of 5.04 and a beta of 1.64. The stock has a 50 day moving average price of $232.37 and a two hundred day moving average price of $267.39.

Align Technology (NASDAQ:ALGN – Get Free Report ) last issued its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share for the quarter, topping the consensus estimate of $2.32 by $0.09. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. Align Technology’s revenue for the quarter was up 2.6% compared to the same quarter last year. In the same period last year, the firm earned $1.73 per share. Sell-side analysts forecast that Align Technology, Inc. will post 7.61 earnings per share for the current year.

Changes in Analyst Ratings

A number of equities research analysts recently commented on ALGN shares. OTR Global reiterated a “mix” rating on shares of Align Technology in a report on Tuesday, June 4th. Stifel Nicolaus dropped their price objective on Align Technology from $400.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, July 25th. StockNews.com downgraded Align Technology from a “buy” rating to a “hold” rating in a report on Sunday, September 1st. Evercore ISI dropped their price objective on Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a report on Monday, June 10th. Finally, Morgan Stanley decreased their price objective on Align Technology from $328.00 to $310.00 and set an “overweight” rating for the company in a report on Thursday, July 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $306.88, based on data from MarketBeat.com.

Get the latest report on Align Technology

Align the profile of the technology company

(Free Report)

Align Technology, Inc designs, manufactures and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general dentists in the United States, Switzerland and internationally. The company’s Clear Aligner segment offers comprehensive products, including the comprehensive Invisalign package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators and eruption compensation; and the Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients, generally between the ages of six and ten, which is a mix of primary/baby and permanent teeth.

Featured stories

Want to see what other hedge funds own ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Get news and reviews for Align Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Align Technology and related companies with MarketBeat.com’s FREE daily email newsletter.